KZIA · Kazia Therapeutics Ltd · Documents
Market Cap
$122.53M
Shares
15.55M
Volume · Oct 21
135.66K
Avg daily vol (3M)
278.94K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 20-F | — | 2022-10-17 | 2022-06-30 | |
| 6-K | — | 2022-10-14 | — | |
| 6-K | — | 2022-09-15 | — | |
| 6-K | — | 2022-09-08 | — | |
| 6-K | — | 2022-09-01 | — | |
| 6-K | — | 2022-08-05 | — | |
| 6-K | — | 2022-08-01 | — | |
| 6-K | — | 2022-07-06 | — | |
| 6-K | — | 2022-06-30 | — | |
| 6-K | — | 2022-06-23 | — | |
| 6-K | — | 2022-06-17 | — | |
| 6-K | — | 2022-04-22 | — | |
| 6-K | — | 2022-04-05 | — | |
| 6-K | — | 2022-03-24 | — | |
| 6-K | — | 2021-12-13 | — | |
| 6-K | — | 2021-12-03 | — | |
| 6-K | — | 2021-11-16 | — | |
| 6-K | — | 2021-11-12 | 2021-11-11 | |
| 6-K | — | 2021-11-10 | — | |
| 6-K | — | 2021-11-10 | — | |
| 6-K | — | 2021-11-05 | 2021-11-04 | |
| 6-K | — | 2021-10-29 | — | |
| 6-K | — | 2021-10-13 | — | |
| 20-F | — | 2021-10-07 | 2021-06-30 | |
| 6-K | — | 2021-09-20 | — | |
| 6-K | — | 2021-06-24 | — | |
| 6-K | — | 2021-04-28 | — | |
| 6-K | — | 2021-04-19 | — | |
| 6-K | — | 2021-04-09 | — | |
| 6-K | — | 2021-03-29 | — | |
| 6-K | — | 2021-03-24 | — | |
| 6-K | — | 2021-03-18 | — | |
| 6-K | — | 2021-03-15 | — | |
| 6-K | — | 2021-03-02 | — | |
| 6-K | — | 2021-03-01 | — | |
| 6-K | — | 2021-01-29 | — | |
| 6-K | — | 2021-01-07 | — | |
| 6-K | — | 2021-01-04 | — | |
| 6-K | — | 2020-12-17 | — | |
| 6-K | — | 2020-12-17 | — | |
| 6-K | — | 2020-12-14 | — | |
| 6-K | — | 2020-12-14 | — | |
| 6-K | — | 2020-12-10 | — | |
| 6-K | — | 2020-12-09 | — | |
| 6-K | — | 2020-11-18 | — | |
| 6-K | — | 2020-11-10 | — | |
| 6-K | — | 2020-11-06 | — | |
| 6-K | — | 2020-11-06 | — | |
| 6-K | — | 2020-10-30 | — | |
| 20-F | — | 2020-10-22 | 2020-06-30 |
Showing 101–150 of 172 filings